Literature DB >> 12925078

Multi-modality approach in curative local treatment of early rectal carcinomas.

M J Hershman1, A Sun Myint, C A Makin.   

Abstract

OBJECTIVE: Despite recent advances, surgery remains the mainstay for the management of rectal carcinoma. The conventional surgical treatment for low rectal carcinoma is total mesorectal excision. This results in either abdomino-perineal excision of the rectum (APER) with permanent colostomy or low anterior resection (LAR) usually with a covering stoma. Local resection is an alternative treatment option and this could be offered either using manual trans-anal resection (TAR) or transanal endoscopic microsurgery (TEM) if the tumour is situated higher. PATIENTS: Patient selection is an important factor if local resection is used. No further treatment is necessary for T1 tumours with clear surgical resection margins. Conventional radical surgery should be offered for T1 tumours with close resection margins (<1 mm) or T2 tumours with higher risk of lymph node metastases. Patients were treated by postoperative chemo-radiotherapy or radiotherapy, if further radical surgery was not considered appropriate or if the patient refused further surgery. Using this approach, we describe our experience of 100 patients treated from January 1992 to June 2002.
RESULTS: Only 13 patients had surgery alone and 87 patients had radiotherapy either pre-operative (33 patients), postoperative (25 patients) or radical radiotherapy alone (29 patients). Local recurrence occurred in 10% of patients and salvage surgery was offered in over half (6 patients) of these patients. At median follow up of 33 months (range 3-120 months), the overall survival was 77% reflecting the fact that the majority of these patients were elderly with coexisting medical problems. However, cancer specific survival was 96%. More importantly, only 9 patients had colostomies and colostomy-free survival in our cohort of patients from Liverpool was 91%.
CONCLUSION: We concluded that in selected patients, who were not medically fit (ASA 111 or above) or those who were unable to accept a permanent colostomy, local treatment could be offered with curative intent using a multimodality approach. In our experience, relapses can be salvaged effectively and we recommend a long-term close follow up policy.

Entities:  

Mesh:

Year:  2003        PMID: 12925078     DOI: 10.1046/j.1463-1318.2003.00502.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  7 in total

Review 1.  Oxaliplatin: in operable colorectal cancer.

Authors:  Susan J Keam; Christopher J Dunn; David P Figgitt
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Organ-Preserving Strategies for the Management of Near-Complete Responses in Rectal Cancer after Neoadjuvant Chemoradiation.

Authors:  Patricio B Lynn; Paul Strombom; Julio Garcia-Aguilar
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

3.  Confocal chromolaser endomicroscopy: a supplemental diagnostic tool prior to transanal endoscopic microsurgery of rectal tumors?

Authors:  Thomas Borschitz; Ralf Kiesslich
Journal:  Int J Colorectal Dis       Date:  2009-11-04       Impact factor: 2.571

4.  Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation?

Authors:  Arthur Sun Myint; Fraser McLean Smith; Simon William Gollins; Helen Wong; Christopher Rao; Karen Whitmarsh; Raj Sripadam; Paul Rooney; Michael Jeremy Hershman; Zsolt Fekete; Kate Perkins; D Mark Pritchard
Journal:  Br J Radiol       Date:  2017-11-10       Impact factor: 3.039

5.  Long-term results of local excision for T1 rectal carcinoma: the experience of two colorectal units.

Authors:  Alexander Lebedyev; Hagit Tulchinsky; Micha Rabau; Joseph M Klausner; Michael Krausz; Simon D Duek
Journal:  Tech Coloproctol       Date:  2009-07-31       Impact factor: 3.781

Review 6.  Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers.

Authors:  Jia-Yuan Peng; Zhong-Nan Li; Yu Wang
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

7.  Update and debate issues in surgical treatment of middle and low rectal cancer.

Authors:  Nam Kyu Kim; Min Sung Kim; Sami F Al-Asari
Journal:  J Korean Soc Coloproctol       Date:  2012-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.